HHSC: Drug Utilization Review Board (Part 1: Drug Class Reviews)

The Texas Drug Utilization Review Board meets quarterly to develop criteria and standards impacting Texas Medicaid, including: developing and submitting recommendations for the Texas Medicaid preferred drug list; suggesting clinical prior authorizations on outpatient prescription drugs; recommending educational interventions for Medicaid providers; and reviewing drug utilization across the Medicaid program. The DUR board is composed of 20 total members: 18 physicians and pharmacists who provide services across the entire population of Medicaid recipients and who represent different specialties, two representatives from Medicaid managed care organizations as nonvoting members, and a consumer advocate representing people enrolled in the Medicaid program. Members include: Robert L. Hogue, M.D., F.A.A.F.M. (Brownwood) (Chair) J. Nile Barnes, Pharm. D., BCPS (Dripping Springs) Scott Blaszczyk, Pharm.D., BCGP (Dallas) Deborah E. Briggs, M.D. (Austin) Marlo Brawner, M